Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
roche
3
×
biotech
boston blog main
boston top stories
clinical trials
europe top stories
fda
national
new york top stories
san francisco top stories
billy dunn
biogen
biopharma
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
companion diagnostic
deals
detroit blog main
detroit top stories
dna sequencing
drug prices
drug pricing
drugs
duchenne
entrectinib
europe blog main
evrysdi
express scripts
foundation medicine
gene therapy
genentech
indiana blog main
indiana top stories
ionis pharmaceuticals
What
fda
3
×
medicine
3
×
approved
drug
new
roche
second
therapy
approval
atrophy
betting
billion
biopharma
cancer
daily
deal
deeper
dna
duchenne
evrysdi
fingerprint
friday
gene
genetic
going
green
historic
home
intended
lights
liquid
matter
muscular
nd
oks
oral
patients
puts
recently
risdiplam
Language
unset
Current search:
roche
×
medicine
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues